Neurocrine Bioscience buy Morgan Stanley
Start price
22.07.25
/
50%
€112.50
Target price
22.07.26
€128.31
Performance (%)
9.60%
Price
22.09.25
€124.25
Summary
This prediction is currently active. The BUY prediction by Morgan_Stanley shows slight gains of 9.60%. This prediction currently runs until 22.07.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | 4.018% | 4.018% |
| iShares Core DAX® | -0.560% | -3.108% |
| iShares Nasdaq 100 | 1.622% | 4.701% |
| iShares Nikkei 225® | 1.807% | 5.094% |
| iShares S&P 500 | 0.859% | 2.906% |
Comments by Morgan_Stanley for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at Morgan Stanley from $148.00 to $150.00. They now have an "overweight" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Morgan_Stanley for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€121.85
05.09.25
05.09.25
€139.74
05.09.26
05.09.26
1.97%
22.09.25
22.09.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€112.45
31.07.25
31.07.25
€138.22
31.07.26
31.07.26
10.49%
22.09.25
22.09.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€105.00
07.03.25
07.03.25
€138.30
07.03.26
07.03.26
18.33%
22.09.25
22.09.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€148.00
04.02.25
04.02.25
€178.90
04.02.26
04.02.26
-16.05%
22.09.25
22.09.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€136.55
12.07.24
12.07.24
€155.89
12.07.25
12.07.25
-17.17%
13.07.25
13.07.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€124.65
12.06.24
12.06.24
€147.54
12.06.25
12.06.25
-14.64%
13.06.25
13.06.25